NCT04249427 - Erenumab for Idiosyncratic Facial Pain | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 10, 2021

Primary Completion Date

July 11, 2023

Study Completion Date

July 11, 2023

Conditions

Facial PainRhinosinusitis

Interventions

DRUG

Erenumab Prefilled Syringe

140mg Erenumab, pre-filled syringe given by subcutaneous injection

OTHER

Placebo

Placebo, pre-filled syringe given by subcutaneous injection

Trial Locations (1)

Duke University Medical Center and affiliated practices, Durham